chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling cold, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: I had a very cold sensation in the middle of my chest/then my lower legs have a on and off cold sensation; tingling; numbness; irritating bilateral pain; This is a spontaneous report from a contactable consumer, other healthcare professional. This 35-year-old female consumer (patient) reported for herself. A 35-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: FC3181), dose 1 via an unspecified route of administration, administered in Arm Left on 24Aug2021 08:45 (at the age of 35-years-old) as a single dose for covid-19 immunization. Medical history included retinal detachment, chronic inflammatory demyelinating polyradiculoneuropathy CIDP, unevaluable event- reaction to Gardasil vaccine. There were no concomitant medications. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Aug2021 09:00, In the first 5 minutes, the patient had a very cold sensation in the middle of her chest with tingling and numbness down the left side of her arm to her fingertips. After 40 minutes that resolved and then her lower legs have a on and off cold sensation with irritating bilateral pains that have become worse each day. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Outcome of the event was not recovered.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Neuropathy; Dizziness; High fever; Body aches; Chills; Shaking; Crying; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: FD8448), via an unspecified route of administration, administered in the right arm on 02Sep2021 09:30 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. Medical history included COVID-19. The patient has no known allergies. Concomitant medications included bupropion, hydroxyzine, and melatonin. On 02Sep2021 21:00, the patient experienced neuropathy, dizziness, high fever, body aches, chills, shaking, and crying. Therapeutic measures were not taken as result of the events. The patient underwent lab tests and procedures which included nasal swab/rapid test: negative on 11Aug2021. The outcome of the events was recovering.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Crying, Dizziness, Neuropathy peripheral, Pain
Clinical narrative: Neuropathy; Dizziness; High fever; Body aches; Chills; Shaking; Crying; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: FD8448), via an unspecified route of administration, administered in the right arm on 02Sep2021 09:30 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. Medical history included COVID-19. The patient has no known allergies. Concomitant medications included bupropion, hydroxyzine, and melatonin. On 02Sep2021 21:00, the patient experienced neuropathy, dizziness, high fever, body aches, chills, shaking, and crying. Therapeutic measures were not taken as result of the events. The patient underwent lab tests and procedures which included nasal swab/rapid test: negative on 11Aug2021. The outcome of the events was recovering.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Tremor
Clinical narrative: Neuropathy; Dizziness; High fever; Body aches; Chills; Shaking; Crying; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number: FD8448), via an unspecified route of administration, administered in the right arm on 02Sep2021 09:30 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. Medical history included COVID-19. The patient has no known allergies. Concomitant medications included bupropion, hydroxyzine, and melatonin. On 02Sep2021 21:00, the patient experienced neuropathy, dizziness, high fever, body aches, chills, shaking, and crying. Therapeutic measures were not taken as result of the events. The patient underwent lab tests and procedures which included nasal swab/rapid test: negative on 11Aug2021. The outcome of the events was recovering.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram normal, Chest X-ray normal, Chest pain, Computerised tomogram normal, Dyspnoea
Clinical narrative: Right side facial drooping; chest pains; shortness of breath; right side tingling; high blood pressure; This is a spontaneous report from a contactable consumer reported for herself. A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: FC3181; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 11:30 (at the age of 28-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included PCOS from an unknown date and unknown if ongoing, caesarean section in Jun2020 C-section for twin birth, pre-eclampsia from Jun2020 to an unknown date, covid-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); sertraline hydrochloride (ZOLOFT); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced right side facial drooping, chest pains, shortness of breath, right side tingling, high blood pressure on 01Sep2021 12:00. AE resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the reported events from Sep2021 to Sep2021 (dates unspecified). Number of days hospitalization reported as one. However, it was also reported that events were not serious and other seriousness criteria included none. The patient underwent lab tests and procedures which included blood pressure: high on 01Sep2021. No treatment received for AE. Clinical outcome of events was recovering.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram normal, Facial paralysis, Full blood count normal, Hypertension, Magnetic resonance imaging normal
Clinical narrative: Right side facial drooping; chest pains; shortness of breath; right side tingling; high blood pressure; This is a spontaneous report from a contactable consumer reported for herself. A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: FC3181; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 11:30 (at the age of 28-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included PCOS from an unknown date and unknown if ongoing, caesarean section in Jun2020 C-section for twin birth, pre-eclampsia from Jun2020 to an unknown date, covid-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); sertraline hydrochloride (ZOLOFT); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced right side facial drooping, chest pains, shortness of breath, right side tingling, high blood pressure on 01Sep2021 12:00. AE resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the reported events from Sep2021 to Sep2021 (dates unspecified). Number of days hospitalization reported as one. However, it was also reported that events were not serious and other seriousness criteria included none. The patient underwent lab tests and procedures which included blood pressure: high on 01Sep2021. No treatment received for AE. Clinical outcome of events was recovering.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean platelet volume decreased, Paraesthesia
Clinical narrative: Right side facial drooping; chest pains; shortness of breath; right side tingling; high blood pressure; This is a spontaneous report from a contactable consumer reported for herself. A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: FC3181; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 11:30 (at the age of 28-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included PCOS from an unknown date and unknown if ongoing, caesarean section in Jun2020 C-section for twin birth, pre-eclampsia from Jun2020 to an unknown date, covid-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); sertraline hydrochloride (ZOLOFT); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced right side facial drooping, chest pains, shortness of breath, right side tingling, high blood pressure on 01Sep2021 12:00. AE resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the reported events from Sep2021 to Sep2021 (dates unspecified). Number of days hospitalization reported as one. However, it was also reported that events were not serious and other seriousness criteria included none. The patient underwent lab tests and procedures which included blood pressure: high on 01Sep2021. No treatment received for AE. Clinical outcome of events was recovering.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Chest pain, Dyspnoea, Facial paralysis, Hypertension
Clinical narrative: Right side facial drooping; chest pains; shortness of breath; right side tingling; high blood pressure; This is a spontaneous report from a contactable consumer reported for herself. A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: FC3181; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 11:30 (at the age of 28-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included PCOS from an unknown date and unknown if ongoing, caesarean section in Jun2020 C-section for twin birth, pre-eclampsia from Jun2020 to an unknown date, covid-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); sertraline hydrochloride (ZOLOFT); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced right side facial drooping, chest pains, shortness of breath, right side tingling, high blood pressure on 01Sep2021 12:00. AE resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the reported events from Sep2021 to Sep2021 (dates unspecified). Number of days hospitalization reported as one. However, it was also reported that events were not serious and other seriousness criteria included none. The patient underwent lab tests and procedures which included blood pressure: high on 01Sep2021. No treatment received for AE. Clinical outcome of events was recovering.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Right side facial drooping; chest pains; shortness of breath; right side tingling; high blood pressure; This is a spontaneous report from a contactable consumer reported for herself. A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: FC3181; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 11:30 (at the age of 28-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included PCOS from an unknown date and unknown if ongoing, caesarean section in Jun2020 C-section for twin birth, pre-eclampsia from Jun2020 to an unknown date, covid-19 (prior vaccination) from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medication(s) included fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); sertraline hydrochloride (ZOLOFT); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on unspecified date. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced right side facial drooping, chest pains, shortness of breath, right side tingling, high blood pressure on 01Sep2021 12:00. AE resulted in Emergency room/department or urgent care, Hospitalization. The patient was hospitalized for the reported events from Sep2021 to Sep2021 (dates unspecified). Number of days hospitalization reported as one. However, it was also reported that events were not serious and other seriousness criteria included none. The patient underwent lab tests and procedures which included blood pressure: high on 01Sep2021. No treatment received for AE. Clinical outcome of events was recovering.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Angiocardiogram, Catheterisation cardiac abnormal, Coronary arterial stent insertion, Coronary artery thrombosis
Clinical narrative: anterior STEMI (ST segment elevated MI); ST segment elevated MI; Thrombus to mid LAD requiring stent; This is a spontaneous report from a contactable healthcare professional. A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Aug2021 (Batch/Lot number was not reported) at the age of 50 years, as dose 1, single for COVID-19 immunisation. Medical history included hypertension (HTN), hyperlipidaemia (HLD), and being a smoker, all from an unknown date and unknown if ongoing. The patient had no known allergies and was not diagnosed with COVID prior to vaccination. Concomitant medication included atorvastatin and lisinopril, both taken for unspecified indications, start and stop dates were not reported (in two weeks). No other vaccine was administered in four weeks. On an unspecified date, the patient was admitted with anterior STEMI (ST segment elevated MI) within 72 hours of first Pfizer vaccine on 21Aug2021. Patient had thrombus to mid LAD requiring stent with other arteries angiographically fine. The patient had no prior cardiac history and timing from vaccine dose concerning. The events resulted in Emergency room/department or urgent care, Hospitalization for 2 days, Life threatening illness (immediate risk of death from the event). Treatment included Stent to mid LAD. Outcome of the events was recovered on an unspecified date.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events myocardial infarction, thrombosis and electrocardiogram ST segment elevation and the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Angiogram, Electrocardiogram ST segment, Electrocardiogram ST segment elevation, Thrombosis
Clinical narrative: anterior STEMI (ST segment elevated MI); ST segment elevated MI; Thrombus to mid LAD requiring stent; This is a spontaneous report from a contactable healthcare professional. A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Aug2021 (Batch/Lot number was not reported) at the age of 50 years, as dose 1, single for COVID-19 immunisation. Medical history included hypertension (HTN), hyperlipidaemia (HLD), and being a smoker, all from an unknown date and unknown if ongoing. The patient had no known allergies and was not diagnosed with COVID prior to vaccination. Concomitant medication included atorvastatin and lisinopril, both taken for unspecified indications, start and stop dates were not reported (in two weeks). No other vaccine was administered in four weeks. On an unspecified date, the patient was admitted with anterior STEMI (ST segment elevated MI) within 72 hours of first Pfizer vaccine on 21Aug2021. Patient had thrombus to mid LAD requiring stent with other arteries angiographically fine. The patient had no prior cardiac history and timing from vaccine dose concerning. The events resulted in Emergency room/department or urgent care, Hospitalization for 2 days, Life threatening illness (immediate risk of death from the event). Treatment included Stent to mid LAD. Outcome of the events was recovered on an unspecified date.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow-up.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events myocardial infarction, thrombosis and electrocardiogram ST segment elevation and the suspect drug BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Computerised tomogram head, Computerised tomogram neck, Ear pain, Eye disorder
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial nerve disorder, Facial pain, Headache, Neck pain, Pain
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tenderness
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Ear pain, Eye disorder, Facial nerve disorder, Facial paralysis
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Musculoskeletal stiffness, Myalgia, Neck pain, Pain in extremity
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vascular pain, Vasodilatation
Clinical narrative: left side of his face feeling paralyzed; left eye smaller; left side neck pain; facial nerve swollen; earache and behind ear as well; Carotid artery swollen and painful; Neck stiffness; Left arm soreness; Carotid artery swollen and painful; muscle tenderness; headache on the left side of my head; This is a spontaneous report from a contactable consumer (reported for himself).   A 34-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: FC3180/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 27Aug2021 (at the age of 34-year-old) as dose 1, single for covid-19 immunisation. Medical history included psoriasis (Inverse Psoriasis), psoriasis (Psoriasis Arthritis) and compartment syndrome from an unknown date and unknown if ongoing. Concomitant medications included otezla (APREMILAST) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that the day after patient received the vaccine, on 28Aug2021, he woke up with a headache on the left side of his head, same side where the vaccine was injected in his left arm. Next noticed his left eye smaller, left side of his face feeling paralyzed, left side neck pain, facial nerve swollen, earache and behind ear as well. Left arm soreness and muscle tenderness. Carotid artery swollen and painful. Neck stiffness. The event left side of his face feeling paralyzed was assessed as serious (medically significant). The reporter stated the events result in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included treatment with Anti-inflammatory drugs. On an unknown date, the patient underwent muscle, Head and Neck Cat Scan. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Angiogram, Asthenia, Bacterial test, Blood lactic acid
Clinical narrative: Neurological disorder; Like my hands get tired quickly; Woke up several time at night; My feet and toes are cold; Weakness/I don't have much energy to keep my hands up a long time; Numbness and Pins and needles on legs and foots/numbness on my wrist and fingers; Numbness and Pins and needles on legs and foots/Pins and needles on my leap; This is a spontaneous case received from a contactable consumer (patient herself). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EWO158), via an unspecified route of administration on 09Apr2021 at 14:45 (age at vaccination 31-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history, known allergies and concomitant medications was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 14:50, the patient experienced numbness and pins and needles on legs and foot all the time when she sits down or lay down on her bed. On 10Apr2021 04:00, the patient woke up several time at night because of numbness/pins and needles. The patient stated that she had same symptoms and additional weakness, her feet and toes were cold, pins and needles on her leap that last few seconds. On 13Apr2021, the patient experienced numbness on her wrist and fingers. On 17Apr2021, the patient stated she had pins and needles at night, it was stronger, and she do not have much energy to keep hands up a long time, like her hands get tired quickly. On 02Sep2021, the patient stated she still have same problems. The Next EMG exam was scheduled on 10Sep. She had visited several Allergists, Neurologists but no health issue was found except neurological disorder caused by the vaccine. On 20Apr2021, the patient visited emergency room. The patient underwent lab test and procedures which included CTA Head W/WO Contrast and lumbar puncture and the results was no health problems found. The treatment for the events was unknown. Seriousness of the events was reported as disabling/incapacitating. The outcome of the events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Blood test normal, CSF cell count, CSF glucose, CSF protein
Clinical narrative: Neurological disorder; Like my hands get tired quickly; Woke up several time at night; My feet and toes are cold; Weakness/I don't have much energy to keep my hands up a long time; Numbness and Pins and needles on legs and foots/numbness on my wrist and fingers; Numbness and Pins and needles on legs and foots/Pins and needles on my leap; This is a spontaneous case received from a contactable consumer (patient herself). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EWO158), via an unspecified route of administration on 09Apr2021 at 14:45 (age at vaccination 31-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history, known allergies and concomitant medications was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 14:50, the patient experienced numbness and pins and needles on legs and foot all the time when she sits down or lay down on her bed. On 10Apr2021 04:00, the patient woke up several time at night because of numbness/pins and needles. The patient stated that she had same symptoms and additional weakness, her feet and toes were cold, pins and needles on her leap that last few seconds. On 13Apr2021, the patient experienced numbness on her wrist and fingers. On 17Apr2021, the patient stated she had pins and needles at night, it was stronger, and she do not have much energy to keep hands up a long time, like her hands get tired quickly. On 02Sep2021, the patient stated she still have same problems. The Next EMG exam was scheduled on 10Sep. She had visited several Allergists, Neurologists but no health issue was found except neurological disorder caused by the vaccine. On 20Apr2021, the patient visited emergency room. The patient underwent lab test and procedures which included CTA Head W/WO Contrast and lumbar puncture and the results was no health problems found. The treatment for the events was unknown. Seriousness of the events was reported as disabling/incapacitating. The outcome of the events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Differential white blood cell count, Electromyogram, Full blood count, Human chorionic gonadotropin
Clinical narrative: Neurological disorder; Like my hands get tired quickly; Woke up several time at night; My feet and toes are cold; Weakness/I don't have much energy to keep my hands up a long time; Numbness and Pins and needles on legs and foots/numbness on my wrist and fingers; Numbness and Pins and needles on legs and foots/Pins and needles on my leap; This is a spontaneous case received from a contactable consumer (patient herself). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EWO158), via an unspecified route of administration on 09Apr2021 at 14:45 (age at vaccination 31-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history, known allergies and concomitant medications was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 14:50, the patient experienced numbness and pins and needles on legs and foot all the time when she sits down or lay down on her bed. On 10Apr2021 04:00, the patient woke up several time at night because of numbness/pins and needles. The patient stated that she had same symptoms and additional weakness, her feet and toes were cold, pins and needles on her leap that last few seconds. On 13Apr2021, the patient experienced numbness on her wrist and fingers. On 17Apr2021, the patient stated she had pins and needles at night, it was stronger, and she do not have much energy to keep hands up a long time, like her hands get tired quickly. On 02Sep2021, the patient stated she still have same problems. The Next EMG exam was scheduled on 10Sep. She had visited several Allergists, Neurologists but no health issue was found except neurological disorder caused by the vaccine. On 20Apr2021, the patient visited emergency room. The patient underwent lab test and procedures which included CTA Head W/WO Contrast and lumbar puncture and the results was no health problems found. The treatment for the events was unknown. Seriousness of the events was reported as disabling/incapacitating. The outcome of the events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, International normalised ratio, Lumbar puncture normal, Metabolic function test, Muscular weakness
Clinical narrative: Neurological disorder; Like my hands get tired quickly; Woke up several time at night; My feet and toes are cold; Weakness/I don't have much energy to keep my hands up a long time; Numbness and Pins and needles on legs and foots/numbness on my wrist and fingers; Numbness and Pins and needles on legs and foots/Pins and needles on my leap; This is a spontaneous case received from a contactable consumer (patient herself). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EWO158), via an unspecified route of administration on 09Apr2021 at 14:45 (age at vaccination 31-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history, known allergies and concomitant medications was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 14:50, the patient experienced numbness and pins and needles on legs and foot all the time when she sits down or lay down on her bed. On 10Apr2021 04:00, the patient woke up several time at night because of numbness/pins and needles. The patient stated that she had same symptoms and additional weakness, her feet and toes were cold, pins and needles on her leap that last few seconds. On 13Apr2021, the patient experienced numbness on her wrist and fingers. On 17Apr2021, the patient stated she had pins and needles at night, it was stronger, and she do not have much energy to keep hands up a long time, like her hands get tired quickly. On 02Sep2021, the patient stated she still have same problems. The Next EMG exam was scheduled on 10Sep. She had visited several Allergists, Neurologists but no health issue was found except neurological disorder caused by the vaccine. On 20Apr2021, the patient visited emergency room. The patient underwent lab test and procedures which included CTA Head W/WO Contrast and lumbar puncture and the results was no health problems found. The treatment for the events was unknown. Seriousness of the events was reported as disabling/incapacitating. The outcome of the events was not recovered.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Peripheral coldness, Prothrombin time, Scan with contrast, Sleep disorder
Clinical narrative: Neurological disorder; Like my hands get tired quickly; Woke up several time at night; My feet and toes are cold; Weakness/I don't have much energy to keep my hands up a long time; Numbness and Pins and needles on legs and foots/numbness on my wrist and fingers; Numbness and Pins and needles on legs and foots/Pins and needles on my leap; This is a spontaneous case received from a contactable consumer (patient herself). A 31-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EWO158), via an unspecified route of administration on 09Apr2021 at 14:45 (age at vaccination 31-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history, known allergies and concomitant medications was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 14:50, the patient experienced numbness and pins and needles on legs and foot all the time when she sits down or lay down on her bed. On 10Apr2021 04:00, the patient woke up several time at night because of numbness/pins and needles. The patient stated that she had same symptoms and additional weakness, her feet and toes were cold, pins and needles on her leap that last few seconds. On 13Apr2021, the patient experienced numbness on her wrist and fingers. On 17Apr2021, the patient stated she had pins and needles at night, it was stronger, and she do not have much energy to keep hands up a long time, like her hands get tired quickly. On 02Sep2021, the patient stated she still have same problems. The Next EMG exam was scheduled on 10Sep. She had visited several Allergists, Neurologists but no health issue was found except neurological disorder caused by the vaccine. On 20Apr2021, the patient visited emergency room. The patient underwent lab test and procedures which included CTA Head W/WO Contrast and lumbar puncture and the results was no health problems found. The treatment for the events was unknown. Seriousness of the events was reported as disabling/incapacitating. The outcome of the events was not recovered.